Device, method and storage medium for monitoring rationality of sedative and hypnotic drug use
By introducing data reception, data query analysis and result feedback modules into the drug monitoring system of sedative hypnotic drugs, the problem of improper use of sedative hypnotic drugs is solved, and automated monitoring and feedback on the rationality of drug use is achieved, and drug safety is improved.
Patent Information
- Application Number
- CN202111074954.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-09-14
- Publication Date
- 2025-03-14
- Estimated Expiration
- 2041-09-14
AI Technical Summary
The existing technology lacks systematic drug monitoring and management, which leads to frequent inappropriate drug use of sedative and hypnotic drugs, especially the problem of overdose or overtime consumption is difficult to effectively monitor.
It provides a rational monitoring device for the use of sedative hypnotic drugs, including a data reception module, a data query analysis module and a result feedback module. By receiving and analyzing the user's medication information, it identifies the rational monitoring object for the use of sedative hypnotic drugs, and feedback is made based on the preset time limit and dosage threshold to remind the user of the time limit or the overdose medication.
Automatic monitoring of sedative and hypnotic drugs is realized, the dependence on manual judgment is reduced, the safety of medication is improved, and users are promptly reminded to use drugs overtime or overdose, avoiding potential health risks.
Smart Images

Figure CN113889222B_ABST
Abstract
Description
Technical Field
[0001] The present application relates to the technical field of computer data processing, and in particular to a device, method, computer equipment and storage medium for monitoring the rationality of the use of sedative and hypnotic drugs. Background Art
[0002] There is currently a lack of systematic medication monitoring and management for sedatives and hypnotic drugs. When a patient visits a doctor, the doctor prescribes sedatives based on the patient's description of the symptoms. Whether the sedatives are taken in excess or for an extended period of time is entirely up to the doctor's manual judgment. In addition, doctors need to prescribe sedatives based on the patient's past medication information. If the patient deliberately conceals past medication information or provides inaccurate past medication information, the sedatives and hypnotic drugs prescribed by the doctor may be improperly used. Therefore, there is an urgent need for an automated monitoring and management system for sedatives and hypnotic drugs. Summary of the invention
[0003] Based on this, it is necessary to provide a device, method, computer equipment and storage medium for monitoring the rationality of the use of sedatives and hypnotic drugs in order to solve the above technical problems.
[0004] A device for monitoring the rationality of the use of sedative hypnotic drugs comprises: a data receiving module for receiving drug information of a user's drug, and obtaining the user's identity information and drug information of the drug when the drug is identified as a sedative hypnotic drug use rationality monitoring object according to the drug information; a data query and analysis module for obtaining the user's first continuous medication time of the longest continuous medication of the drug in history, the second continuous medication time of the drug prescribed at the time, the first diazepam dose of the longest daily medication taken at history, and the second diazepam dose of the drug taken at the time according to the user's identity information and the drug information of the drug; and a result feedback module for feeding back the medication information of the user at the time and the medication information of the historical user according to a first condition and a second condition, wherein the first condition is determined based on the comparison relationship between the first continuous medication time and a first preset time limit threshold and the comparison relationship between the first diazepam dose and the first preset dose threshold, and the second condition is determined based on the comparison relationship between the second continuous medication time and the second preset time limit threshold and the comparison relationship between the second diazepam dose and the second preset dose threshold.
[0005] In one of the embodiments, the data receiving module includes: a matching unit, which is used to receive drug information of the user's medication and match the drug information with the type information of the sedative-hypnotic drug to be monitored; an identification unit, which is used to identify the medication as a sedative-hypnotic drug that is a medication rationality monitoring object when the drug information matches the type information; and an acquisition unit, which is used to acquire the user's identity information and the medication information of the medication when the medication is a sedative-hypnotic drug that is a medication rationality monitoring object.
[0006] In one embodiment, the data query and analysis module includes: a first calculation unit, which is used to obtain the user's historical sedative hypnotic drug purchase information according to the user's identity information, and calculate the first continuous medication time according to the historical sedative hypnotic drug purchase information; a second calculation unit, which is used to obtain the first duration of the user's continuous medication according to the user's identity information and calculate the second duration of the medication that can be taken continuously according to the medication information of the medication, and calculate the second continuous medication time according to the first duration and the second duration; a third calculation unit, which is used to obtain the user's historical sedative hypnotic drug purchase information according to the user's identity information and calculate the second continuous medication time according to the first duration and the second duration; a calculation unit for obtaining an equivalent diazepam conversion table corresponding to the sedative and hypnotic drug, and calculating a second diazepam dose according to the equivalent diazepam conversion table and the drug information of the medication drug; a fourth calculation unit for obtaining a first equivalent diazepam dose of the sedative and hypnotic drug of the user within a historical evaluation time limit, distributing the first equivalent diazepam dose in the medication date according to the medication method, obtaining a second equivalent diazepam dose within a specified time range in the medication date, and dividing the second equivalent diazepam dose by the duration of the specified time to obtain the first diazepam dose.
[0007] In one embodiment, the data query and analysis module includes: a setting unit, used to set a first preset time limit threshold, a first preset dosage threshold, a second preset time limit threshold and a second preset dosage threshold; a prompt unit, used to perform a prompt operation if the second continuous medication time is greater than or equal to the second preset time limit threshold, or the second diazepam dosage is greater than or equal to the second preset dosage threshold; a storage unit, used to store the first preset time limit threshold, the first preset dosage threshold, the second preset time limit threshold and the second preset dosage threshold, the second continuous medication time and the second diazepam dosage in a temporary database.
[0008] In one of the embodiments, a device for monitoring the rationality of the use of sedative hypnotic drugs also includes: an update module, which is used to update and check the drug information of sedative hypnotic drugs in a temporary database according to a preset update time, and if the drug information exists in the temporary database, write the drug information into a hot database; the update module is also used to write the drug information in the hot database that meets the time limit requirements into a cold database.
[0009] In one of the embodiments, the cold database is also used to store the purchase data information of the sedative-hypnotic drugs that will not affect the overtime or overdose of the drugs, and the hot database is also used to store the purchase data information of the sedative-hypnotic drugs that will affect the overtime or overdose of the drugs.
[0010] In one embodiment, the result feedback module includes: a first feedback unit, which is used to feedback the user's historical overtime medication information when the first continuous medication time in the first condition is greater than or equal to the first preset time limit threshold, and feedback the user's current overtime medication information when the second continuous medication time in the second condition is greater than or equal to the second preset time limit threshold; a second feedback unit, which is used to feedback the user's historical overdose medication information when the first diazepam dose in the first condition is greater than or equal to the first preset dose threshold, and feedback the user's current overdose medication information when the second diazepam dose in the second condition is greater than or equal to the second preset dose threshold.
[0011] A method for monitoring the rationality of the use of sedative hypnotic drugs comprises: receiving drug information of a user's drugs, and when the drug is identified as a sedative hypnotic drug use rationality monitoring object according to the drug information, obtaining the user's identity information and the drug information of the drugs; obtaining the user's first continuous medication time of the longest continuous medication of the drug in history, the second continuous medication time of the drug prescribed at the time, the first diazepam dose of the longest daily medication taken in history, and the second diazepam dose of the drug taken at the time according to the user's identity information and the drug information of the drugs; feeding back the medication information of the user at the time and the medication information of the historical users according to a first condition and a second condition, the first condition being determined based on the comparison relationship between the first continuous medication time and a first preset time limit threshold and the comparison relationship between the first diazepam dose and the first preset dose threshold, and the second condition being determined based on the comparison relationship between the second continuous medication time and the second preset time limit threshold and the comparison relationship between the second diazepam dose and the second preset dose threshold.
[0012] A computer device includes a memory, a processor, and a computer program stored in the memory and executable on the processor. When the processor executes the computer program, the steps of any of the above-mentioned embodiments are implemented.
[0013] A computer-readable storage medium stores a computer program, which implements the steps of any of the above-mentioned method embodiments when the computer program is executed by a processor.
[0014] The above-mentioned sedative-hypnotic drug use rationality monitoring device, method, computer equipment and storage medium receive the drug information of the user's drug use, and when the drug is identified as a sedative-hypnotic drug use rationality monitoring object based on the drug information, obtain the user's identity information and the drug information of the drug; obtain the user's first continuous medication time of the maximum continuous medication of the user in history, the second continuous medication time of the medication prescribed for the time, the first diazepam dose of the maximum daily medication taken in history, and the second diazepam dose of the medication taken on the current day based on the user's identity information and the drug information of the medication; feedback the medication information of the current user and the medication information of the historical users based on the first condition and the second condition, the first condition is determined based on the comparison relationship between the first continuous medication time and the first preset time limit threshold and the comparison relationship between the first diazepam dose and the first preset dose threshold, and the second condition is determined based on the comparison relationship between the second continuous medication time and the second preset time limit threshold and the comparison relationship between the second diazepam dose and the second preset dose threshold. Therefore, the rationality of the user's use of sedative hypnotic drugs is monitored through the feedback of the current user's medication information and the historical user's medication information, thereby realizing automatic monitoring of the rationality of the use of sedative hypnotic drugs. BRIEF DESCRIPTION OF THE DRAWINGS
[0015] Figure 1 It is a structural block diagram of a device for monitoring the rationality of the use of sedative hypnotic drugs in one embodiment;
[0016] Figure 2 It is a schematic diagram of a method for monitoring the rationality of the use of sedative hypnotic drugs in one embodiment;
[0017] Figure 3 FIG. 4 is a diagram showing the internal structure of a computer device in one embodiment. DETAILED DESCRIPTION
[0018] In order to make the purpose, technical solution and advantages of the present application more clearly understood, the present application is further described in detail below in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain the present application and are not used to limit the present application.
[0019] The present application provides a device for monitoring the rationality of the use of sedative hypnotic drugs, which is applied to a drug supervision system. Figure 1 As shown, in one embodiment, a device 100 for monitoring the rationality of sedative and hypnotic drug use includes a data receiving module 102 , a data query and analysis module 104 , and a result feedback module 106 .
[0020] The data receiving module 102 is used to receive the drug information of the user's medication. When the medication is identified as a sedative hypnotic drug as a medication rationality monitoring object based on the drug information, the user's identity information and the drug information of the medication are obtained.
[0021] In this embodiment, the data receiving module 102 is used to receive the drug information of the user's medication. The drug information includes the identification information of the medication, such as the identification code of the medication or the drug name of the medication. In addition, the medication supervision system pre-configures the medication rationality monitoring object of sedative hypnotic drugs. When any medication belongs to the medication rationality monitoring object, the medication supervision system performs rationality monitoring on any medication.
[0022] When the data receiving module 102 identifies the medication as a sedative hypnotic medication rationality monitoring object based on the medication information, the user's identity information and the medication information of the medication are obtained. The user's identity information includes one or more of the user's identity code, gender information, and age information, and the medication information of the medication includes one or more of the identification information of the medication, the dosage, and the usage method of the medication. It can be that the user's identity information and the medication information of the medication are obtained by receiving. It can also be that the user's identity information and the medication information of the medication are pre-stored, and the user's identity information and the medication information of the medication are obtained by reading.
[0023] The data query and analysis module 104 is used to obtain the user's first continuous medication time of the maximum continuous medication in history, the second continuous medication time of the medication prescribed that time, the first diazepam dose of the maximum daily medication taken in history, and the second diazepam dose of the medication taken that time according to the user's identity information and medication information.
[0024] In this embodiment, the data query and analysis module 104 obtains the relevant information of the user's historical medication according to the user's identity information, and identifies the first continuous medication time of the user's historical maximum continuous medication and the first diazepam dose of the historical maximum daily medication according to the relevant information. The data query and analysis module 104 identifies the second continuous medication time of the medication prescribed and the second diazepam dose of the medication taken on the current day according to the medication information of the medication.
[0025] The result feedback module 106 is used to feedback the medication information of the current user and the medication information of historical users according to the first condition and the second condition, wherein the first condition is determined based on the comparison relationship between the first continuous medication time and the first preset time limit threshold and the comparison relationship between the first diazepam dose and the first preset dose threshold, and the second condition is determined based on the comparison relationship between the second continuous medication time and the second preset time limit threshold and the comparison relationship between the second diazepam dose and the second preset dose threshold.
[0026] In this embodiment, the first condition and the second condition are pre-configured in the drug supervision system. In the first condition, the comparison relationship between the first continuous medication time and the first preset time limit threshold is used as one of the reference factors, and the comparison relationship between the first diazepam dose and the first preset dose threshold is used as another reference factor. In the second condition, the comparison relationship between the second continuous medication time and the second preset time limit threshold is used as one of the reference factors, and the comparison relationship between the second diazepam dose and the second preset dose threshold is used as another reference factor. The result feedback module 106 is used to feedback the medication information of the historical user according to the first condition and feedback the medication information of the current user according to the second condition. The medication information of the historical user can characterize the rationality of the medication of the sedative hypnotic drugs taken by the user in history, and the medication information of the current user can characterize the rationality of the medication of the sedative hypnotic drugs taken by the user at that time.
[0027] The above-mentioned sedative-hypnotic drug use rationality monitoring device receives the drug information of the user's drug use, and when the drug is identified as a sedative-hypnotic drug use rationality monitoring object based on the drug information, the user's identity information and the drug information of the drug are obtained; the user's first continuous medication time of the maximum continuous medication of the drug in history, the second continuous medication time of the medication prescribed at the time, the first diazepam dose of the maximum daily medication taken in history, and the second diazepam dose of the medication taken at the time are obtained based on the user's identity information and the drug information of the medication; the medication information of the current user and the medication information of the historical users are fed back based on the first condition and the second condition, the first condition is determined based on the comparison relationship between the first continuous medication time and the first preset time limit threshold and the comparison relationship between the first diazepam dose and the first preset dose threshold, and the second condition is determined based on the comparison relationship between the second continuous medication time and the second preset time limit threshold and the comparison relationship between the second diazepam dose and the second preset dose threshold. Therefore, the rationality of the user's use of sedative hypnotic drugs is monitored through the feedback of the current user's medication information and the historical user's medication information, thereby realizing automatic monitoring of the rationality of the use of sedative hypnotic drugs.
[0028] In one embodiment, the data receiving module includes a matching unit, an identification unit and an acquisition unit. The matching unit is used to receive the drug information of the user's medication and match the drug information with the type information of the sedative hypnotic drug to be monitored; the identification unit is used to identify the medication as a sedative hypnotic drug for medication rationality monitoring when the drug information matches the type information; the acquisition unit is used to acquire the user's identity information and the medication information of the medication when the medication is a sedative hypnotic drug for medication rationality monitoring.
[0029] In this embodiment, the drug information of the user's medication is received. The drug information can be the drug information prescribed by the doctor for the user, and the drug information is matched with the type of sedative hypnotic drugs that need to be monitored in the database. If the match fails, it indicates that the prescribed medication is a non-sedative hypnotic drug, and no subsequent operation is performed; if the match is successful, the user's identity information and the drug information of the medication are obtained. The user's identity information and the drug information of the medication include the user's identification ID, gender, age, and information such as the prescribed drugs, dosage, and usage, and the information is transmitted to the data query analysis module 104. Therefore, the objects of monitoring the rationality of the use of sedative hypnotic drugs can be automatically screened out.
[0030] In one embodiment, the data query analysis module includes a first calculation unit, a second calculation unit, a third calculation unit and a fourth calculation unit. The first calculation unit is used to obtain the user's historical sedative hypnotic drug purchase information based on the user's identity information, and calculate the first continuous medication time based on the historical sedative hypnotic drug purchase information; the second calculation unit is used to obtain the first duration of the user's continuous medication based on the user's identity information and calculate the second duration of the medication that can be continuously taken based on the medication information of the medication, and calculate the second continuous medication time based on the first duration and the second duration; the third calculation unit is used to obtain the equivalent diazepam conversion table corresponding to the sedative hypnotic drug, and calculate the second diazepam dose based on the equivalent diazepam conversion table and the medication information of the medication; the fourth calculation unit is used to obtain the first equivalent diazepam dose of the user's sedative hypnotic drug within the historical evaluation time limit, distribute the first equivalent diazepam dose in the medication date according to the medication method, obtain the second equivalent diazepam dose within the specified time range in the medication date, and divide the second equivalent diazepam dose by the specified time duration to obtain the first diazepam dose.
[0031] In this embodiment, the first continuous medication time is calculated based on the historical sedative hypnotic drug purchase information. For example, the sedative hypnotic drug purchase information is read from the database, and the user's historical maximum continuous medication information is screened from the sedative hypnotic drug purchase information, and then the first continuous medication time is calculated. That is, the user's maximum first continuous medication time D1 before the current visit is obtained. And, based on the user's identity information, the first duration of the user's continuous medication is obtained, and the second duration of the medication that can be taken continuously is calculated based on the medication information of the medication, and the second continuous medication time is obtained based on the first duration and the second market. For example, the continuous medication time during this visit is obtained, and the continuous medication time for this prescription is added as the second continuous medication time D2 after the prescription.
[0032] The method of obtaining the second diazepam dose and the first diazepam dose is, for example: according to the equivalent diazepam conversion table corresponding to sedative hypnotic drugs, the equivalent diazepam weight of the drug prescribed this time is calculated, and according to the method of taking the drug, these doses are distributed in the dates of taking the drug on time in the future. At the same time, the equivalent diazepam of sedative hypnotic drugs that have been prescribed recently in the database but are within the evaluation time limit is distributed in the available dates according to the method of taking the drug. Finally, the total equivalent diazepam dose within the specified time range is calculated and divided by the length of time to obtain the daily equivalent diazepam dose M2; directly from the database The largest daily average medication equivalent diazepam dose M1. At this time, the daily equivalent diazepam dose M2 is the second diazepam dose, and the daily average medication equivalent diazepam dose M1 is the first diazepam dose.
[0033] In one embodiment, the data query and analysis module includes a setting unit, a prompting unit, and a storage unit. The setting unit is used to set a first preset time limit threshold, a first preset dosage threshold, a second preset time limit threshold, and a second preset dosage threshold; the prompting unit is used to perform a prompting operation if the second continuous medication time is greater than or equal to the second preset time limit threshold, or the second diazepam dosage is greater than or equal to the second preset dosage threshold; the storage unit is used to store the first preset time limit threshold, the first preset dosage threshold, the second preset time limit threshold, the second preset dosage threshold, the second continuous medication time, and the second diazepam dosage in a temporary database.
[0034] In this embodiment, for example, the specified time range defaults to 90 days, and the average daily equivalent diazepam dose for the thirty days before and sixty days after the diagnosis and prescription is calculated. These values are all default values and can be adjusted as needed. Assume that the first preset time limit threshold and the second preset time limit threshold are both BoundDay, the default value is 120 days, and the first preset dose threshold and the second preset dose threshold are both BoundMg, the default value is 60mg. If the second continuous medication time D2 is not less than BoundDay, or the second diazepam dose M2 is not less than BoundMg, the relevant data is passed to the result feedback module, and a pop-up window prompt is performed. The default validity period of the first continuous medication time D1 and the first diazepam dose M1 is 1 year. The effective time limit can be set in the configuration file as needed. After the validity period is exceeded, the first continuous medication time D1 and the first diazepam dose M1 are automatically updated to the maximum value within the subsequent effective time range. The information related to this prescription obtained by calculation will be stored in the temporary database.
[0035] In one embodiment, the above-mentioned sedative hypnotic drug use rationality monitoring device further includes an update module. The update module is used to check the drug information of the sedative hypnotic drug in the temporary database according to the preset update time, and if the drug information exists in the temporary database, the drug information is written into the hot database; the update module is also used to write the drug information in the hot database that meets the time limit requirement into the cold database.
[0036] Among them, the cold database is also used to store the purchase data information of sedative hypnotic drugs that will not affect the overtime or overdose of medication, and the hot database is also used to store the purchase data information of sedative hypnotic drugs that will affect the overtime or overdose of medication.
[0037] In this embodiment, the drug information of sedative hypnotic drugs in the temporary database is updated and checked based on the preset update time, and the preset update time can be set to one or more idle time points every day. For example, the update module is used to check the prescription information related to sedative hypnotic drugs and the corresponding drug purchase information during the idle time of the day. If there is corresponding drug purchase information, the data containing the drug information of sedative hypnotic drugs stored in the temporary data table is written into the hot database. In addition, the update module is also used to update and check the information in the hot database. When the countdown mark moved into the cold database is less than 0, the drug information corresponding to the mark is removed from the hot database and written into the cold database to reduce the corresponding storage pressure and query and calculation time. For example, the update module decides whether to write the relevant information into the hot database based on whether the patient purchases the drug.
[0038] The database includes a cold database and a hot database, and the data query and analysis module can query data or write data from the cold database and the hot database. Among them, the cold database stores the drug purchase data information that will not affect the overtime or overdose medication according to the current settings. For example, only the user, such as the patient, corresponding unique identification code, gender, age, diagnosis, drug-related information, and abnormal information are stored. Abnormal information refers to the information that the patient's unique identification code does not match the corresponding gender or age. The hot database stores the relevant data that will affect the overtime or overdose medication according to the current setting time. In addition to the data information stored in the cold database, it also includes the data vector of the daily medication dosage within the medication time limit, the countdown mark moved into the cold database, the current number of consecutive medication days, the maximum number of consecutive medication days so far, and the maximum daily average medication equivalent diazepam dose so far. Among them, the countdown mark moved into the cold database is equal to the sum of the length of time that the medication can be taken this time and the time for calculating the second diazepam dose M2.
[0039] In one embodiment, the result feedback module includes a first feedback unit and a second feedback unit. The first feedback unit is used to feedback the user's historical overtime medication information when the first continuous medication time in the first condition is greater than or equal to the first preset time limit threshold, and feedback the user's current overtime medication information when the second continuous medication time in the second condition is greater than or equal to the second preset time limit threshold; the second feedback unit is used to feedback the user's historical overdose medication information when the first diazepam dose in the first condition is greater than or equal to the first preset dose threshold, and feedback the user's current overdose medication information when the second diazepam dose in the second condition is greater than or equal to the second preset dose threshold.
[0040] In this embodiment, when the first continuous medication time is greater than or equal to the first preset time limit threshold, the user's historical overtime medication information is fed back, and when the second continuous medication time is greater than or equal to the second preset time limit threshold, the user's current overtime medication information is fed back, otherwise no overtime reminder is given. When the first diazepam dose is greater than or equal to the first preset dose threshold, the user's historical overdose medication information is fed back, and when the second diazepam dose is greater than or equal to the second preset dose threshold, the user's current overdose medication information is fed back, otherwise no overdose reminder is given.
[0041] Several situations in which information feedback is performed based on the first condition and the second condition are given below, as shown in the following table. Among them, the specific expressions of D1, D2, M1, and M2 are as described in the above embodiments. Condition 1 is determined based on D2, M2, BoundDay, and BoundMg, and condition 2 is determined based on D1, M1, BoundDay, and BoundMg. Condition 1 is not the above-mentioned first condition, and condition 2 is not the above-mentioned second condition. Specifically, if the result feedback module does not receive a message, it will not start and will not provide any feedback; if the received information contains D1, D2, M1, and M2, the feedback information is as shown in the following table:
[0042]
[0043]
[0044] The feedback information in the above table is only an example of possible feedback. In actual use, different display methods can be defined according to the situation to ensure that the feedback information reminder is more eye-catching and distinctive.
[0045] The above-mentioned device for monitoring the rationality of the use of sedative hypnotic drugs can exist as a plug-in of the existing hospital system, or as an independent system software, depending on whether the current hospital system supports additional supplementary plug-in functions and which method is more convenient to use. In the device for monitoring the rationality of the use of sedative hypnotic drugs, the data receiving module can be used as a data receiving component of the software or plug-in, the data query and analysis module can be used as a data query and analysis component of the software or plug-in, the result feedback module can be used as a result feedback component of the software or plug-in, and the update module can be used as an update component of the software or plug-in.
[0046] Each module in the above-mentioned sedative hypnotic drug rationality monitoring device can be implemented in whole or in part by software, hardware and a combination thereof. Each of the above-mentioned modules can be embedded in or independent of a processor in a computer device in the form of hardware, or can be stored in a memory in a computer device in the form of software, so that the processor can call and execute the operations corresponding to each of the above modules.
[0047] The present application also provides a method for monitoring the rationality of the use of sedative hypnotic drugs. Figure 2 As shown, the following steps are included:
[0048] S202, receiving medication information of the user's medication, and when the medication is identified as a sedative hypnotic drug as a medication rationality monitoring target based on the medication information, obtaining the user's identity information and the medication information of the medication.
[0049] S204, based on the user's identity information and medication information, obtain the user's first continuous medication time of the longest continuous medication, the second continuous medication time of the medication prescribed that time, the first diazepam dose of the longest daily medication, and the second diazepam dose of the medication prescribed that time.
[0050] S206, feeding back the medication information of the current user and the medication information of historical users according to the first condition and the second condition, the first condition being determined based on the comparison relationship between the first continuous medication time and the first preset time limit threshold and the comparison relationship between the first diazepam dose and the first preset dose threshold, and the second condition being determined based on the comparison relationship between the second continuous medication time and the second preset time limit threshold and the comparison relationship between the second diazepam dose and the second preset dose threshold.
[0051] In one embodiment, medication information of a user's medications is received, and when the medication is identified as a sedative-hypnotic drug as a medication rationality monitoring target based on the medication information, the user's identity information and medication information of the medication are obtained, including: receiving medication information of the user's medications, matching the medication information with type information of sedative-hypnotic drugs to be monitored; when the medication information matches the type information, identifying the medication as a sedative-hypnotic drug as a medication rationality monitoring target; when the medication is a sedative-hypnotic drug as a medication rationality monitoring target, obtaining the user's identity information and medication information of the medication.
[0052] In one embodiment, the first continuous medication time of the user's maximum continuous medication, the second continuous medication time of the medication prescribed at the time, the first diazepam dose of the maximum daily medication, and the second diazepam dose of the medication taken at the time are obtained according to the user's identity information and the medication information of the medication, including: obtaining the user's historical sedative hypnotic drug purchase information according to the user's identity information, calculating the first continuous medication time according to the historical sedative hypnotic drug purchase information; obtaining the first duration of the user's continuous medication at the time according to the user's identity information and the medication information of the medication. The information is used to calculate the second duration that the medication can be taken continuously, and the second continuous medication time is calculated according to the first duration and the second duration; the equivalent diazepam conversion table corresponding to the sedative and hypnotic drugs is obtained, and the second diazepam dose is calculated according to the equivalent diazepam conversion table and the drug information of the medication drugs; the first equivalent diazepam dose of the sedative and hypnotic drugs of the user within the historical evaluation time limit is obtained, and the first equivalent diazepam dose is distributed in the medication date according to the medication method, and the second equivalent diazepam dose within the specified time range in the medication date is obtained, and the second equivalent diazepam dose is divided by the duration of the specified time to obtain the first diazepam dose.
[0053] In one embodiment, the above-mentioned method for monitoring the rationality of medication of sedative hypnotic drugs also includes: setting a first preset time limit threshold, a first preset dosage threshold, a second preset time limit threshold and a second preset dosage threshold; if the second continuous medication time is greater than or equal to the second preset time limit threshold, or the second diazepam dosage is greater than or equal to the second preset dosage threshold, then a prompt operation is performed; the first preset time limit threshold, the first preset dosage threshold, the second preset time limit threshold and the second preset dosage threshold, the second continuous medication time and the second diazepam dosage are stored in a temporary database.
[0054] In one embodiment, the above-mentioned method for monitoring the rationality of the use of sedative hypnotic drugs also includes: updating and checking the drug information of sedative hypnotic drugs in the temporary database according to the preset update time, if the drug information exists in the temporary database, writing the drug information into the hot database; and writing the drug information in the hot database that meets the time limit requirements into the cold database.
[0055] In one embodiment, the cold database is also used to store the purchase data information of sedative hypnotic drugs that will not affect the overtime limit or overdose of medication, and the hot database is also used to store the purchase data information of sedative hypnotic drugs that will affect the overtime limit or overdose of medication.
[0056] In one embodiment, the above-mentioned feedback of the current user's medication information and historical users' medication information according to the first condition and the second condition includes: when the first continuous medication time in the first condition is greater than or equal to the first preset time limit threshold, the user's historical overtime medication information is fed back; when the second continuous medication time in the second condition is greater than or equal to the second preset time limit threshold, the user's current overtime medication information is fed back; when the first diazepam dose in the first condition is greater than or equal to the first preset dose threshold, the user's historical overdose medication information is fed back; when the second diazepam dose in the second condition is greater than or equal to the second preset dose threshold, the user's current overdose medication information is fed back.
[0057] For more definitions of the technical features in a method for monitoring the rationality of the use of sedatives and hypnotic drugs, please refer to the above description of the corresponding modules or units in a device for monitoring the rationality of the use of sedatives and hypnotic drugs, which will not be repeated here.
[0058] In some embodiments, a computer-readable storage medium is provided, on which a computer program is stored. In different embodiments, when the computer program is executed by a processor, the steps performed by each functional module or functional unit of the device for monitoring the rationality of the use of sedatives and hypnotic drugs described in the previous embodiments are respectively implemented.
[0059] Those skilled in the art can understand that all or part of the process of the method for monitoring the rationality of the use of sedative hypnotic drugs can be completed by instructing related hardware through a computer program. The aforementioned computer program can be stored in a non-volatile computer-readable storage medium. When the computer program is executed, it can include the process of the embodiments of the above-mentioned methods. Among them, any reference to memory, storage, database or other media used in the embodiments provided in this application may include non-volatile and / or volatile memory. Non-volatile memory may include read-only memory (ROM), programmable ROM (PROM), electrically programmable ROM (EPROM), electrically erasable programmable ROM (EEPROM) or flash memory. Volatile memory may include random access memory (RAM) or external cache memory. By way of illustration and not limitation, RAM is available in many forms, such as static RAM (SRAM), dynamic RAM (DRAM), synchronous DRAM (SDRAM), double data rate SDRAM (DDRSDRAM), enhanced SDRAM (ESDRAM), synchronous link (Synchlink) DRAM (SLDRAM), memory bus (Rambus) direct RAM (RDRAM), direct memory bus dynamic RAM (DRDRAM), and memory bus dynamic RAM (RDRAM), etc.
[0060] In one embodiment, a computer device is provided. The computer device may be a server, and its internal structure diagram may be as follows: Figure 3 As shown. The computer device includes a processor, a memory, a network interface and a database connected through a system bus. Among them, the processor of the computer device is used to provide computing and control capabilities. The memory of the computer device includes a non-volatile storage medium and an internal memory. The non-volatile storage medium stores an operating system, a computer program and a database. The internal memory provides an environment for the operation of the operating system and the computer program in the non-volatile storage medium. The network interface of the computer device is used to connect to an external terminal to receive a video stream of the user's facial expression uploaded by the terminal. When the computer program is executed by the processor, a method for monitoring the rationality of the use of sedative hypnotic drugs is implemented.
[0061] Those skilled in the art will understand that Figure 3 The structure shown in the figure is only a block diagram of a part of the structure related to the solution of the present application, and does not constitute a limitation on the computer device to which the solution of the present application is applied. The specific computer device may include more or fewer components than those shown in the figure, or combine certain components, or have a different arrangement of components.
[0062] In one embodiment, a computer device is provided, comprising a memory, a processor, and a computer program stored in the memory and executable on the processor, wherein the processor implements the following steps when executing the computer program: receiving drug information of a user's medication, and when the medication is identified as a sedative-hypnotic drug as a medication rationality monitoring target based on the drug information, obtaining the user's identity information and the medication information of the medication; obtaining the user's first continuous medication time of the maximum continuous medication in history, the second continuous medication time of the medication prescribed at the time, the first diazepam dose of the maximum daily medication taken in history, and the second diazepam dose of the average daily medication taken at the time based on the user's identity information and the medication information of the medication; and feeding back the medication information of the current user and the medication information of the historical users based on a first condition and a second condition, wherein the first condition is determined based on a comparison relationship between the first continuous medication time and a first preset time limit threshold and a comparison relationship between the first diazepam dose and the first preset dose threshold, and the second condition is determined based on a comparison relationship between the second continuous medication time and a second preset time limit threshold and a comparison relationship between the second diazepam dose and the second preset dose threshold.
[0063] In one of the embodiments, the processor executes a computer program to implement the above-mentioned step of receiving the drug information of the user's medication drugs, and when the medication drug is identified as a sedative-hypnotic drug as a medication rationality monitoring target based on the drug information, the following steps are specifically implemented: receiving the drug information of the user's medication drugs, matching the drug information with the type information of the sedative-hypnotic drugs to be monitored; when the drug information matches the type information, identifying the medication drug as a sedative-hypnotic drug as a medication rationality monitoring target; when the medication drug is a sedative-hypnotic drug as a medication rationality monitoring target, obtaining the user's identity information and medication information of the medication drug.
[0064] In one embodiment, when the processor executes a computer program to implement the above-mentioned steps of obtaining the first continuous medication time of the user's historical maximum continuous medication, the second continuous medication time of the medication prescribed at the time, the first diazepam dose of the historical maximum average daily medication, and the second diazepam dose of the medication taken at the time according to the user's identity information and medication information, the following steps are specifically implemented: obtaining the user's historical sedative hypnotic drug purchase information according to the user's identity information, calculating the first continuous medication time according to the historical sedative hypnotic drug purchase information; obtaining the first continuous medication time that the user has taken continuously according to the user's identity information duration and calculate the second duration that the medication can be taken continuously according to the medication information of the medication, and calculate the second continuous medication time according to the first duration and the second duration; obtain the equivalent diazepam conversion table corresponding to the sedative and hypnotic drugs, and calculate the second diazepam dose according to the equivalent diazepam conversion table and the medication information of the medication; obtain the first equivalent diazepam dose of the sedative and hypnotic drugs of the user within the historical evaluation time limit, distribute the first equivalent diazepam dose in the medication date according to the medication method, obtain the second equivalent diazepam dose within the specified time range in the medication date, divide the second equivalent diazepam dose by the duration of the specified time, and obtain the first diazepam dose.
[0065] In one of the embodiments, when the processor executes the computer program, the following steps are also implemented: setting a first preset time limit threshold, a first preset dosage threshold, a second preset time limit threshold and a second preset dosage threshold; if the second continuous medication time is greater than or equal to the second preset time limit threshold, or the second diazepam dosage is greater than or equal to the second preset dosage threshold, a prompt operation is performed; the first preset time limit threshold, the first preset dosage threshold, the second preset time limit threshold and the second preset dosage threshold, the second continuous medication time and the second diazepam dosage are stored in a temporary database.
[0066] In one of the embodiments, when the processor executes the computer program, the following steps are also implemented: the drug information of the sedative hypnotic drugs in the temporary database is updated and checked according to the preset update time, and if the drug information exists in the temporary database, the drug information is written into the hot database; and the drug information in the hot database that meets the time limit requirement is written into the cold database.
[0067] In one of the embodiments, the cold database is also used to store the purchase data information of the sedative-hypnotic drugs that will not affect the overtime or overdose of the drugs, and the hot database is also used to store the purchase data information of the sedative-hypnotic drugs that will affect the overtime or overdose of the drugs.
[0068] In one of the embodiments, when the processor executes a computer program to implement the above-mentioned step of feeding back the medication information of the current user and the medication information of historical users according to the first condition and the second condition, the following steps are specifically implemented: when the first continuous medication time in the first condition is greater than or equal to the first preset time limit threshold, the user's historical overtime medication information is fed back; when the second continuous medication time in the second condition is greater than or equal to the second preset time limit threshold, the user's current overtime medication information is fed back; when the first diazepam dose in the first condition is greater than or equal to the first preset dose threshold, the user's historical overdose medication information is fed back; when the second diazepam dose in the second condition is greater than or equal to the second preset dose threshold, the user's current overdose medication information is fed back.
[0069] In one embodiment, a computer-readable storage medium is provided, on which a computer program is stored, and when the computer program is executed by a processor, the following steps are implemented: receiving drug information of a user's medication, and when the medication is identified as a sedative-hypnotic drug as a medication rationality monitoring object based on the drug information, obtaining the user's identity information and the medication information of the medication; obtaining the user's first continuous medication time of the maximum continuous medication in history, the second continuous medication time of the medication prescribed at the time, the first diazepam dose of the maximum daily medication taken in history, and the second diazepam dose of the medication taken at the time based on the user's identity information and the medication information of the medication; feeding back the medication information of the current user and the medication information of historical users based on a first condition and a second condition, the first condition being determined based on the comparison relationship between the first continuous medication time and a first preset time limit threshold and the comparison relationship between the first diazepam dose and the first preset dose threshold, and the second condition being determined based on the comparison relationship between the second continuous medication time and the second preset time limit threshold and the comparison relationship between the second diazepam dose and the second preset dose threshold.
[0070] In one of the embodiments, the computer program is executed by the processor to implement the above-mentioned steps of receiving the drug information of the user's medication drugs, and when the medication drug is identified as a sedative-hypnotic drug as a medication rationality monitoring target based on the drug information, obtaining the user's identity information and the drug information of the medication drug, specifically implementing the following steps: receiving the drug information of the user's medication drugs, matching the drug information with the type information of the sedative-hypnotic drugs to be monitored; when the drug information matches the type information, identifying the medication drug as a sedative-hypnotic drug as a medication rationality monitoring target; when the medication drug is a sedative-hypnotic drug as a medication rationality monitoring target, obtaining the user's identity information and the drug information of the medication drug.
[0071] In one embodiment, when the computer program is executed by the processor to implement the above-mentioned steps of obtaining the user's historical maximum continuous medication time, the second continuous medication time of the prescribed medication, the historical maximum average daily first diazepam dose of the medication, and the average daily second diazepam dose of the medication according to the user's identity information and medication information, the following steps are specifically implemented: obtaining the user's historical sedative hypnotic drug purchase information according to the user's identity information, calculating the first continuous medication time according to the historical sedative hypnotic drug purchase information; obtaining the user's current maximum daily medication time according to the user's identity information. a time period and a second time period during which the medication can be taken continuously according to the medication information of the medication, and a second continuous medication time is calculated according to the first time period and the second time period; an equivalent diazepam conversion table corresponding to the sedative and hypnotic drug is obtained, and a second diazepam dose is calculated according to the equivalent diazepam conversion table and the medication information of the medication; the first equivalent diazepam dose of the sedative and hypnotic drug of the user within the historical evaluation time limit is obtained, the first equivalent diazepam dose is distributed in the medication date according to the medication method, the second equivalent diazepam dose within the specified time range in the medication date is obtained, and the second equivalent diazepam dose is divided by the specified time period to obtain the first diazepam dose.
[0072] In one of the embodiments, when the computer program is executed by the processor, the following steps are also implemented: setting a first preset time limit threshold, a first preset dosage threshold, a second preset time limit threshold and a second preset dosage threshold; if the second continuous medication time is greater than or equal to the second preset time limit threshold, or the second diazepam dosage is greater than or equal to the second preset dosage threshold, a prompt operation is performed; the first preset time limit threshold, the first preset dosage threshold, the second preset time limit threshold and the second preset dosage threshold, the second continuous medication time and the second diazepam dosage are stored in a temporary database.
[0073] In one of the embodiments, when the computer program is executed by the processor, the following steps are also implemented: the drug information of sedative hypnotic drugs in the temporary database is updated and checked according to the preset update time, and if the drug information exists in the temporary database, the drug information is written into the hot database; and the drug information in the hot database that meets the time limit requirement is written into the cold database.
[0074] In one of the embodiments, the cold database is also used to store the purchase data information of the sedative-hypnotic drugs that will not affect the overtime or overdose of the drugs, and the hot database is also used to store the purchase data information of the sedative-hypnotic drugs that will affect the overtime or overdose of the drugs.
[0075] In one embodiment, when the computer program is executed by the processor to implement the above-mentioned steps of feeding back the medication information of the current user and the medication information of historical users according to the first condition and the second condition, the following steps are specifically implemented: when the first continuous medication time in the first condition is greater than or equal to the first preset time limit threshold, the user's historical overtime medication information is fed back; when the second continuous medication time in the second condition is greater than or equal to the second preset time limit threshold, the user's current overtime medication information is fed back; when the first diazepam dose in the first condition is greater than or equal to the first preset dose threshold, the user's historical overdose medication information is fed back; when the second diazepam dose in the second condition is greater than or equal to the second preset dose threshold, the user's current overdose medication information is fed back.
[0076] Those skilled in the art can understand that all or part of the processes in the above-mentioned embodiment methods can be completed by instructing the relevant hardware through a computer program, and the computer program can be stored in a non-volatile computer-readable storage medium. When the computer program is executed, it can include the processes of the embodiments of the above-mentioned methods. Among them, any reference to memory, storage, database or other media used in the embodiments provided in this application can include non-volatile and / or volatile memory. Non-volatile memory can include read-only memory (ROM), programmable ROM (PROM), electrically programmable ROM (EPROM), electrically erasable programmable ROM (EEPROM) or flash memory. Volatile memory can include random access memory (RAM) or external cache memory. As an illustration and not limitation, RAM is available in many forms, such as static RAM (SRAM), dynamic RAM (DRAM), synchronous DRAM (SDRAM), double data rate SDRAM (DDRSDRAM), enhanced SDRAM (ESDRAM), synchronous link (Synchlink) DRAM (SLDRAM), memory bus (Rambus) direct RAM (RDRAM), direct memory bus dynamic RAM (DRDRAM), and memory bus dynamic RAM (RDRAM).
[0077] In the embodiment of the present invention, one or more of the user's identity identification code, gender information, and age information are obtained with the user's consent, and all the user data obtained complies with relevant policies and legal regulations.
[0078] The technical features of the above embodiments may be combined arbitrarily. To make the description concise, not all possible combinations of the technical features in the above embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.
[0079] The above-mentioned embodiments only express several implementation methods of the present application, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the scope of the invention patent. It should be pointed out that, for a person of ordinary skill in the art, several variations and improvements can be made without departing from the concept of the present application, and these all belong to the protection scope of the present application. Therefore, the protection scope of the patent of the present application shall be subject to the attached claims.
Claims
1. A device for monitoring the rationality of the use of sedative hypnotic drugs, the device comprising: A data receiving module, used to receive drug information of a user's medication, and when the medication is identified as a sedative hypnotic drug as a medication rationality monitoring object according to the medication information, obtain the user's identity information and the medication information of the medication; A data query and analysis module, for obtaining, based on the identity information of the user and the drug information of the drug, the first continuous medication time of the user's maximum continuous medication, the second continuous medication time of the drug prescribed on the current occasion, the first diazepam dose of the drug taken on the historical maximum average daily basis, and the second diazepam dose of the drug taken on the current average daily basis; a result feedback module, for feeding back the medication information of the user at the time and the medication information of the user in history according to a first condition and a second condition, wherein the first condition is determined based on a comparison relationship between the first continuous medication time and a first preset time limit threshold and a comparison relationship between the first diazepam dose and a first preset dose threshold, and the second condition is determined based on a comparison relationship between the second continuous medication time and a second preset time limit threshold and a comparison relationship between the second diazepam dose and a second preset dose threshold; Wherein, the data receiving module includes: A matching unit, used to receive drug information of a user's medication, and match the drug information with type information of sedative hypnotic drugs to be monitored; an identification unit, configured to identify the medication as a sedative hypnotic medication rationality monitoring object when the medication information matches the category information; an acquisition unit, configured to acquire the identity information of the user and the drug information of the drug when the drug is a sedative hypnotic drug that is the subject of medication rationality monitoring; The data query and analysis module includes: a first calculation unit, configured to obtain the user's historical sedative-hypnotic drug purchase information according to the user's identity information, and calculate the first continuous medication time according to the historical sedative-hypnotic drug purchase information; a second calculation unit, configured to obtain, based on the identity information of the user, a first duration for which the user has continuously taken the medication, and to calculate, based on the medication information of the medication, a second duration for which the medication can be continuously taken, and to calculate the second continuous medication time based on the first duration and the second duration; a third calculation unit, configured to obtain an equivalent diazepam conversion table corresponding to the sedative hypnotic drug, and calculate the second diazepam dosage according to the equivalent diazepam conversion table and the drug information of the drug; a fourth calculation unit, configured to obtain a first equivalent diazepam dose of the sedative hypnotic drug of the user within a historical evaluation time limit, distribute the first equivalent diazepam dose on a medication date according to a medication method, obtain a second equivalent diazepam dose within a specified time range on the medication date, and divide the second equivalent diazepam dose by the duration of the specified time to obtain the first diazepam dose; The result feedback module comprises: A first feedback unit is configured to feedback the user's historical overtime medication information when the first continuous medication time in the first condition is greater than or equal to the first preset time limit threshold, and feedback the user's current overtime medication information when the second continuous medication time in the second condition is greater than or equal to the second preset time limit threshold; The second feedback unit is used to feedback the user's historical overdose information when the first diazepam dose is greater than or equal to the first preset dose threshold in the first condition, and to feedback the user's current overdose information when the second diazepam dose is greater than or equal to the second preset dose threshold in the second condition.
2. The device according to claim 1, characterized in that The data query and analysis module includes: A setting unit, configured to set the first preset time limit threshold, the first preset dose threshold, the second preset time limit threshold, and the second preset dose threshold; a prompting unit, configured to perform a prompting operation if the second continuous medication time is greater than or equal to the second preset time limit threshold, or the second diazepam dose is greater than or equal to the second preset dose threshold; A storage unit is used to store the first preset time limit threshold, the first preset dosage threshold, the second preset time limit threshold, the second preset dosage threshold, the second continuous medication time, and the second diazepam dosage in a temporary database.
3. The device according to claim 2, characterized in that The device also includes: An updating module, used for checking the drug information of the sedative hypnotic drugs in the temporary database for updating according to a preset updating time, and writing the drug information into a hot database if the drug information exists in the temporary database; The update module is also used to write the drug information in the hot database that meets the time limit requirement into the cold database.
4. The device according to claim 3, characterized in that The cold database is also used to store the purchase data information of the sedative-hypnotic drugs that will not affect the overtime or overdose of medication, and the hot database is also used to store the purchase data information of the sedative-hypnotic drugs that will affect the overtime or overdose of medication.
5. A method for monitoring the rationality of the use of sedative hypnotic drugs, characterized in that: The method comprises: receiving drug information of a user's medication, and when the medication is identified as a sedative hypnotic drug as a medication rationality monitoring target based on the medication information, obtaining the user's identity information and the medication information of the medication; According to the identity information of the user and the drug information of the drug, the first continuous medication time of the user's maximum continuous medication, the second continuous medication time of the drug prescribed on the current occasion, the first diazepam dose of the drug taken on the historical maximum average daily basis, and the second diazepam dose of the drug taken on the current average daily basis are obtained; Feedback the medication information of the user at the time and the medication information of the user in history according to the first condition and the second condition, wherein the first condition is determined based on the comparison relationship between the first continuous medication time and the first preset time limit threshold and the comparison relationship between the first diazepam dose and the first preset dose threshold, and the second condition is determined based on the comparison relationship between the second continuous medication time and the second preset time limit threshold and the comparison relationship between the second diazepam dose and the second preset dose threshold; The receiving of drug information of the user's medication, when the medication is identified as a sedative-hypnotic drug as a medication rationality monitoring target according to the medication information, obtaining the user's identity information and the medication information of the medication, includes: receiving the user's medication information, matching the medication information with the type information of the sedative-hypnotic drug to be monitored; when the medication information matches the type information, identifying the medication as a sedative-hypnotic drug as a medication rationality monitoring target; when the medication is a sedative-hypnotic drug as a medication rationality monitoring target, obtaining the user's identity information and the medication information of the medication; The method of obtaining the first continuous medication time of the user's maximum continuous use of the medication, the second continuous medication time of the medication prescribed at the time, the first diazepam dose of the medication taken at the maximum daily average use, and the second diazepam dose of the medication taken at the current time according to the identity information of the user and the medication information of the medication includes: obtaining the user's historical sedative hypnotic drug purchase information according to the identity information of the user, and calculating the first continuous medication time according to the historical sedative hypnotic drug purchase information; obtaining the first duration of the user's continuous medication at the current time according to the identity information of the user, and calculating the first continuous medication time according to the medication information of the medication. Calculate the second duration that the medication can be taken continuously, and calculate the second continuous medication time according to the first duration and the second duration; obtain the equivalent diazepam conversion table corresponding to the sedative and hypnotic drugs, and calculate the second diazepam dose according to the equivalent diazepam conversion table and the drug information of the medication; obtain the first equivalent diazepam dose of the sedative and hypnotic drugs of the user within the historical evaluation time limit, distribute the first equivalent diazepam dose in the medication date according to the medication method, obtain the second equivalent diazepam dose within the specified time range of the medication date, and divide the second equivalent diazepam dose by the duration of the specified time to obtain the first diazepam dose; The method of feeding back the medication information of the user at the time and the medication information of the user in history according to the first condition and the second condition, wherein the first condition is determined based on the comparison relationship between the first continuous medication time and the first preset time limit threshold and the comparison relationship between the first diazepam dose and the first preset dose threshold, and the second condition is determined based on the comparison relationship between the second continuous medication time and the second preset time limit threshold and the comparison relationship between the second diazepam dose and the second preset dose threshold, includes: feeding back the historical overtime medication information of the user when the first continuous medication time in the first condition is greater than or equal to the first preset time limit threshold, and feeding back the current overtime medication information of the user when the second continuous medication time in the second condition is greater than or equal to the second preset time limit threshold; feeding back the historical overdose medication information of the user when the first diazepam dose in the first condition is greater than or equal to the first preset dose threshold, and feeding back the current overdose medication information of the user when the second diazepam dose in the second condition is greater than or equal to the second preset dose threshold.
6. A computer device comprising a memory, a processor and a computer program stored in the memory and executable on the processor, characterized in that: When the processor executes the computer program, the steps of the method according to claim 5 are implemented.
7. A computer-readable storage medium having a computer program stored thereon, characterized in that: When the computer program is executed by a processor, the steps of the method according to claim 5 are implemented.
Citation Information
Patent Citations
Adverse drug reaction early warning and analyzing system and method
CN105760698A
Drug management method and device based on disease monitoring
CN110444266A